申请人:KYOWA HAKKO KOGYO CO., LTD.
公开号:EP0312051A2
公开(公告)日:1989-04-19
Novel tricyclic compounds having a TXA2-antagonizing activity represented by formul (I):
which strongly antagonize an action of thromboxane A2 and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.
具有以式(I)为代表的 TXA2-拮抗活性的新型三环化合物:
它们能强烈拮抗血栓素 A2 的作用,有望对缺血性疾病、脑血管疾病等起到预防和治疗作用。